VPA1 DCF Valuation - Aveo Pharmaceuticals Inc

A

Watchlist Manager

Watchlist

Price: 13.77 EUR -0.4% Market Closed

Market Cap: €478.7m

A	Aveo Pharmaceuticals Inc F:VPA1	US
	Shinhung Co Ltd KRX:004080	KR
	Eastern Pioneer Driving School Co Ltd SSE:603377	CN
	New Century Resources Ltd ASX:NCZ	AU
	Henan Jinma Energy Co Ltd HKEX:6885	CN
	MT Hoejgaard Holding A/S CSE:MTHH	DK
K	Kisan Mouldings Ltd BSE:530145	IN
G	Givaudan SA OTC:GVDBF	CH
	Shenghe Resources Holding Co Ltd SSE:600392	CN
M	Munjal Showa Ltd NSE:MUNJALSHOW	IN
T	Thrace Plastics Holding and Commercial SA ATHEX:PLAT	GR
	Federal Screw Works OTC:FSCR	US
B	Bank Hapoalim BM TASE:POLI	IL
	Spirent Communications plc LSE:SPT	UK
	Witz Corp TSE:4440	JP
	Helia Group Ltd ASX:HLI	AU
M	Marks and Spencer Group PLC SWB:MA6	UK
S	Shuangliang Eco-Energy Systems Co Ltd SSE:600481	CN
	Nippon Signal Co Ltd TSE:6741	JP
M	Manhattan Corp Ltd ASX:MHC	AU

VPA1's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.